References
- Northrup H, Krueger DA. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 2013;49:243-54
- Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet 2008;372:657-68
- Rosser T, Panigrahy A, McClintock W. The diverse clinical manifestations of tuberous sclerosis complex: a review. Semin Pediatr Neurol 2006;13:27-36
- Tuberous Sclerosis Alliance. What is TSC? Silver Spring, Maryland, USA: National Tuberous Sclerosis Association Inc, 2013. http://www.tsalliance.org/pages.aspx?content=2. Accessed June 1, 2015
- TSA. Consultation on the United Kingdom plan for rare diseases: submission from the Tuberous Sclerosis Association. London: TSA, 2012. http://www.google.co.uk/url?sa=t&rct=j&q=&esrc=s&frm =1&source=web&cd =1&ved =0CCIQFjAA&url=http%3A%2F%2Fwww.tuberous-sclerosis.org%2F_literature_124492%2FTSA_Publications_-_Consultation_on_the_UK_Plan_for_Rare_Diseases&ei =9Y5cVf7-B8jwUqjAgegB&usg=AFQjCNFKNKdnMhY1rCEjliZ6mxNaqzOJtQ&bvm=bv.93756505. Accessed June 1, 2015
- European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993;75:1305-15
- Huang J, Manning BD. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J 2008;412:179-90
- van SM, de HR, Hermans C, Nellist M, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997;277:805-8
- Au KS, Williams AT, Roach ES, et al. Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med 2007;9:88-100
- Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med 2006;355:1345-56
- Dabora SL, Jozwiak S, Franz DN, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001;68:64-80
- Jones AC, Shyamsundar MM, Thomas MW, et al. Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 1999;64:1305-15
- Kozlowski P, Roberts P, Dabora S, et al. Identification of 54 large deletions/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations. Hum Genet 2007;121:389-400
- Niida Y, Lawrence-Smith N, Banwell A, et al. Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis. Hum Mutat 1999;14:412-22
- Sancak O, Nellist M, Goedbloed M, et al. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype–phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex. Eur J Hum Genet 2005;13:731-41
- Kingswood C, Bolton P, Crawford P, et al. The clinical profile of tuberous sclerosis complex (TSC) in the United Kingdom: a retrospective cohort study in the Clinical Practice Research Datalink. EJPN 2015;30:1-13
- Harris-Stith R, Elston DM. Tuberous sclerosis. Cutis 2002;69:103-9
- Jozwiak S, Nabbout R, Curatolo P, Participants of the T. S. C. C. M. F. S. & Epilepsy, M. Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): clinical recommendations. Eur J Paediatr Neurol 2013;17:348-52
- O'Callaghan FJ, Noakes MJ, Martyn CN, et al. An epidemiological study of renal pathology in tuberous sclerosis complex. BJU Int 2004;94:853-7
- Curatolo P, Jozwiak S, Nabbout R, SEGA T. S. C. C. M. F. & epilepsy, M. Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations. Eur J Paediatr Neurol 2012;16:582-6
- Cudzilo CJ, Szczesniak RD, Brody AS, et al. Lymphangioleiomyomatosis screening in women with tuberous sclerosis. Chest 2013;144:578-85
- Viner R. Transition from pediatric to adult care. Bridging the gaps or passing the buck? Arch Dis Child 1999;81:271-5
- Lennert B, Farrelly E, Sacco P, et al. Resource utilization in children with tuberous sclerosis complex and associated seizures: a retrospective chart review study. J Child Neurol 2013;28:461-9
- Rentz AM, Skalicky AM, Liu Z, et al. Tuberous sclerosis complex: a survey of health care resource use and health burden. Pediatr Neurol 2015;52:435-41
- Eijkemans MJ, van der Wal W, Reijnders LJ, et al. Long-term Follow-up assessing renal angiomyolipoma treatment patterns, morbidity, and mortality: an observational study in tuberous sclerosis complex patients in the Netherlands. Am J Kidney Dis 2015;66:638-45
- Vekeman F, Magestro M, Karner P, et al. Kidney involvement in tuberous sclerosis complex: the impact on healthcare resource use and costs. J Med Econ 2015;18:1060-70
- Williams T, van Staa T, Puri S, Eaton S. Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource. Ther Adv Drug Saf 2012;3:89-99
- Garcia Rodriguez LA, Perez GS. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998;45:419-25
- Herrett E, Gallagher AM, Bhaskaran K, et al. Data Resource Profile: Clinical Practice Research Datalink. Int J Epidemiol 2015;44:1-10
- Ipsos Mori. GP Patient Survey - National Summary Report. London: Ipsos Mori, 2014. http://gp-survey-production.s3.amazonaws.com/archive/2014/July/1301375001_Y8W2%20National%20Summary%20Report_FINAL%20v1.pdf. Accessed August 6, 2015
- Satterthwaite FE. Synthesis of Variance. Psychometrike 1941; 6:309-16
- PSSRU. Unit Costs of Health and Social Care; Kent, UK: PSSRU, 2007. http://www.pssru.ac.uk/pdf/uc/uc2007/uc2007_s01.pdf 01. Accessed June 2015
- Department of Health. NHS Reference Costs. London: Department of Health, 2014. https://www.gov.uk/government/collections/nhs-reference-costs. Accessed June 1, 2015
- NHS. Drug Tariff; Surrey, UK: NHS, 2015. http://www.nhsbsa.nhs.uk/PrescriptionServices/4940.aspx. Accessed June 1, 2015
- Hallet L, Foster T, Liu Z, et al. Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review. Curr Med Res Opin 2011;27:1571-83
- Chu-Shore CJ, Major P, Camposano S, et al. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 2010;51:1236-4
- Thiele EA. Managing epilepsy in tuberous sclerosis complex. J Child Neurol 2004;19:680-6
- Franz DN, Bissler JJ, McCormack FX. Tuberous sclerosis complex: neurological, renal, and pulmonary manifestations. Neuropediatrics 2010;41:199-208
- Roach ES, DiMario FJ, Kandt RS, et al. Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. J Child Neurol 1999;14:401-7
- Neumann HP, Bruggen V, Berger DP, et al. Tuberous sclerosis complex with end-stage renal failure. Nephrol Dial Transplant 1995;10:349-53
- Skalicky AM, Rentz AM, Liu Z, et al. The burden of Subependymal Giant Cell Astrocytomas associated with tuberous sclerosis complex: results of a patient and caregiver survey. J Child Neurol 2014;30:563-9
- Neumann HP, Schwarzkopf G, Henske EP. Renal angiomyolipomas, cysts, and cancer in tuberous sclerosis complex. Semin Pediatr Neurol 1998;5:269-75
- Hancock E, Tomkins S, Sampson J, et al. Lymphangioleiomyomatosis and tuberous sclerosis. Respir Med 2002;96:7-13
- Seibert D, Hong CH, Takeuchi F, et al. Recognition of tuberous sclerosis in adult women: delayed presentation with life-threatening consequences. Ann Intern Med 2011;154:806-13
- Cudzilo CJ, Szczesniak RD, Brody AS, et al. Lymphangioleiomyomatosis screening in women with tuberous sclerosis. Chest 2013;144:578-85
- Johnson SR, Cordier JF, Lazor R, et al; Review Panel of the ERS LAM Task Force. European Respiratory Society guidelines for the diagnosis and management of lymphanioleiomyomatosis. ERJ 2010;35:14-26
- Rentz AM, Skalicky AM, Pashos CL, et al. Caring for children with tuberous sclerosis complex: what is the physical and mental health impact on caregivers? Journal of Child Neurology 2015;30:1574-81